Lisa Salvatore
机构: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
每年引用次数
引用次数
引用: 7,291
H-指数: 40
I10-指数 : 84
出版物: 319
Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer.
FRANCESCO PASQUALETTI , SABRINA MONTRONE , CATERINA VIVALDI , MARGHERITA ZANI
Anticancer Research 37 ( 1) 315 -319
12
2017
Studio di farmacogenetica prospettico nel trattamento con bevacizumab del carcinoma colorettale
LISA SALVATORE
2012
Challenges in Crohn’s Disease Management after Gastrointestinal Cancer Diagnosis
Sergio Alfieri , Luigi Larosa , Fausto Rosa , Giampaolo Tortora
Cancers 13 ( 3) 574
2021
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis
Matteo Fassan , Massimo Milione , Giulia Maddalena , Chiara Cremolini
European Journal of Cancer 146 145 -154
2021
A Novel ATM Pathogenic Variant in an Italian Woman with Gallbladder Cancer.
Angelo Minucci , Paola Concolino , Elisa De Paolis , Giampaolo Tortora
Genes 12 ( 2) 313
2021
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients' data from 3 phase III studies.
Axel Hinke , Isabella Sperduti , Valérie Boige , Emilio Bria
Cancer Treatment Reviews 97 102202 -102202
2021
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study).
Emilio Bria , Emilio Bria , Alessandra Auriemma , Armando Orlandi
Cancers 13 ( 9) 2098
2021
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection.
Felice Giuliante , Maria Vellone , Tonia Cenci , Maurizio Martini
Cancers 13 ( 9) 2148 -2163
2021
Genetic variants of genes in CCL5/CCR5 pathway to predict regorafenib-induced hand-foot skin reaction in patients with refractory metastatic colorectal cancer: A report of ethnic difference.
Mitsukuni Suenaga , Marta Schirripa , Shu Cao , Wu Zhang
Journal of Clinical Oncology 35 615 -615
1
2017
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin‐based chemotherapy in patients with metastatic colorectal cancer
Satoshi Okazaki , Marta Schirripa , Fotios Loupakis , Shu Cao
Cancer 123 ( 22) 4506 -4514
11
2017
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management.
Michela Del Prete , Riccardo Giampieri , Fotios Loupakis , Tiziana Prochilo
Oncotarget 6 ( 32) 33982 -33992
31
2015
PD-0016 KSR1 Gene Polymorphism in Mcrc Patients Treated with First-Line Folfiri and Bevacizumab
Marta Schirripa , Fotios Loupakis , Chiara Cremolini , Yang Dongyun
Annals of Oncology 23
2012
P-0262 Prospective Evaluation of Candidate Snps of Vegf/Vegfr Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line Folfiri Plus Bevacizumab (BV)
Chiara Cremolini , Fotios Loupakis , Dongyun Yang , Lisa Salvatore
Annals of Oncology 23
2012
P-0221 Folfoxiri Plus Bevacizumab as First-Line Treatment of Braf Mutant Metastatic Colorectal Cancer Patients
Lisa Salvatore , Fotios Loupakis , Chiara Cremolini , Marta Schirripa
Annals of Oncology 23
1
2012
Atypical RAS Mutations in Metastatic Colorectal Cancer
Filippo Pietrantonio , Rona Yaeger , Alexa B. Schrock , Giovanni Randon
JCO Precision Oncology ( 3) 1 -11
2019
Upfront Chemotherapy Regimens in Unresectable Disease: One, Two, or Three Cytotoxics?
Chiara Cremolini , Fotios Loupakis , Carlotta Antoniotti , Lisa Salvatore
Current Colorectal Cancer Reports 8 ( 3) 153 -160
2012
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
Chiara Cremolini , , Federica Marmorino , Fotios Loupakis
BMC Cancer 17 ( 1) 408 -408
12
2017
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
Francesca Battaglin , Marta Schirripa , Federica Buggin , Filippo Pietrantonio
BMC Cancer 18 ( 1) 98 -98
3
2018
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
Paola Muti , Isabella Sperduti , Diana Giannarelli , Francesco Cognetti
Journal of Experimental & Clinical Cancer Research 29 ( 1) 58 -58
79
2010